Global State of Harm Reduction: 2025 Update to Key Data
The 2025 update summarises key developments in harm reduction services, funding and drug policy since the launch of the 9th edition of the report in November 2024. More
Recent materials
Addressing Policy Barriers to Scaling up Needle and Syringe Programmes: A Global Call to Action
Scaling up needle and syringe programmes is essential for achieving global infectious disease-elimination goals and improving health outcomes among people who inject drugs. More
WHO Launches New Framework to Tackle Drug Resistance to HIV, Hepatitis B and C, and STIs
The Framework outlines a unified global approach to address drug resistance, a growing threat that risks undermining decades of progress toward ending AIDS and the epidemics of hepatitis B, hepatitis C, and STIs. More
Global Progress Toward WHO 2030 Hepatitis C Elimination Targets
New global data show limited progress toward WHO’s 2030 hepatitis C elimination goals, highlighting disparities in diagnosis and treatment access. More
The Global Burden of Injecting Drug Use, HIV, Hepatitis and TB in Prisons: Findings from INHSU 2025
The findings are clear: disease burden in prisons is extraordinarily high, and without addressing health disparities in carceral settings, global efforts to eliminate HIV, viral hepatitis, and TB will continue to fall short. More
Development Dimensions of Drug Policy: Assessing New Challenges, Uncovering Opportunities, and Addressing Emerging Issues
UNDP releases a discussion paper examining how drug policy affects sustainable development, human rights, governance, health, and the environment. More
